UPLC-MS/MS Method for Simultaneous Determination of 14 Antimicrobials in Human Plasma and Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring.
Huiting SunHan XingXueke TianXiaojian ZhangJing YangPeile WangPublished in: Journal of analytical methods in chemistry (2022)
Pharmacokinetics/pharmacodynamics is the foundation for guiding the rational application of antibiotics in clinical practice, so it is necessary to establish quantitative methods for accurate drug concentration determination. This study aimed to develop a rapid and simple ultrahigh-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for simultaneous quantification of 14 antibiotics (amikacin, etimicin, ceftazidime, cefepime, cefoperazone, ceftriaxone, daptomycin, latamoxef, linezolid, meropenem, biapenem, ampicillin, norvancomycin, and vancomycin) in human plasma and cerebrospinal fluid. Antibiotics were chromatographically separated on a Waters ACQUITY UPLC BEH C18 column (2.1 mm × 50 mm, 1.7 μ m) via gradient elution within 3 minutes and were monitored using positive ion fitted with multiple reaction monitoring. The lower limit of quantification was 0.05-2.0 μ g·mL -1 . The method was verified according to the FDA bioanalysis method validation guidelines, which showed excellent accuracy (from 86.75% to 110.85%) and precision (from 0.46% to 10.97%). At last, this method was successfully applied to therapeutic drug monitoring in 113 patients under antibiotics treatment.
Keyphrases
- simultaneous determination
- liquid chromatography tandem mass spectrometry
- solid phase extraction
- cerebrospinal fluid
- high performance liquid chromatography
- liquid chromatography
- tandem mass spectrometry
- clinical practice
- ultra high performance liquid chromatography
- methicillin resistant staphylococcus aureus
- molecularly imprinted
- end stage renal disease
- ejection fraction
- newly diagnosed
- high resolution
- chronic kidney disease
- mass spectrometry
- gas chromatography
- emergency department
- high resolution mass spectrometry
- combination therapy
- gram negative
- multidrug resistant
- smoking cessation